Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Ludlam

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 17, 2026
UK Infected Blood Inquiry-An Historical AppraisalChristopher A Ludlam
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
The evidence behind inhibitor treatment with recombinant factor VIIaChristopher A Ludlam
British Journal of Haematology|December 24, 2005
Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood productsChristopher A Ludlam, Marc L Turner
British Journal of Haematology|March 16, 2007
Plasma microparticles and vascular disordersSusan F Lynch, Christopher A Ludlam
British Journal of Haematology|October 28, 2008
An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma productsMarc L Turner, Christopher A Ludlam
British Journal of Haematology|February 10, 2011
Microparticles, malignancy and thrombosisSharon Zahra, Julia A M Anderson, David Stirling, et al.
Journal of Vascular Surgery|April 5, 2002
Hemostatic markers before operation in patients with acutely symptomatic nonruptured and ruptured infrarenal abdominal aortic aneurysmDonald J Adam, Paul C Haggart, Christopher A Ludlam, et al.
Journal of the American College of Cardiology|January 22, 2003
Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in menStanley Chia, Christopher A Ludlam, Keith A A Fox, et al.
Thrombosis Research|September 26, 2002
A novel method for quantitation of human von Willebrand factor messenger RNARon Kerr, David Stirling, Marion Rae, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 28, 2007
Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart diseaseSimon D Robinson, Christopher A Ludlam, Nicholas A Boon, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 17, 2026
UK Infected Blood Inquiry-An Historical AppraisalChristopher A Ludlam
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
The evidence behind inhibitor treatment with recombinant factor VIIaChristopher A Ludlam
British Journal of Haematology|December 24, 2005
Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood productsChristopher A Ludlam, Marc L Turner
British Journal of Haematology|March 16, 2007
Plasma microparticles and vascular disordersSusan F Lynch, Christopher A Ludlam
British Journal of Haematology|October 28, 2008
An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma productsMarc L Turner, Christopher A Ludlam
British Journal of Haematology|February 10, 2011
Microparticles, malignancy and thrombosisSharon Zahra, Julia A M Anderson, David Stirling, et al.
Journal of Vascular Surgery|April 5, 2002
Hemostatic markers before operation in patients with acutely symptomatic nonruptured and ruptured infrarenal abdominal aortic aneurysmDonald J Adam, Paul C Haggart, Christopher A Ludlam, et al.
Journal of the American College of Cardiology|January 22, 2003
Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in menStanley Chia, Christopher A Ludlam, Keith A A Fox, et al.
Thrombosis Research|September 26, 2002
A novel method for quantitation of human von Willebrand factor messenger RNARon Kerr, David Stirling, Marion Rae, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 28, 2007
Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart diseaseSimon D Robinson, Christopher A Ludlam, Nicholas A Boon, et al.
Pageof 4